{ "report_id": "security_gh", "report_type": "security_detail", "site_path": "securities/gh/index.html", "title": "GH - Guardant Health Operating Console", "ticker": "GH", "company": "Guardant Health", "as_of": "2026-07-04T17:26:59.231168Z", "generated_at": "2026-07-05T09:12:41-07:00", "summary": "Static report-layer operating console projection of the canonical GH knowledge lane, with a live selected-security chart host, source-routed proof blocks, operating evidence, guidance tests, scenarios, risks, diagnostics, and dated source links.", "boundaries": { "canonical_research_storage": "../../../knowledge/wiki/lanes/security/gh.md", "report_role": "Readable projection, routing surface, and chart host only.", "discovery_policy": "Read local report API outputs only; do not mutate discovery from this page.", "chart_rules_policy": "Persisted chart overlays and plan rules remain in assets/chart-level-rules.js.", "portfolio_policy": "No portfolio action, sizing, buy/sell recommendation, or trade instruction is stored in this report." }, "freshness": { "knowledge_lane_reviewed_as_of": "2026-07-04T17:26:59.231168Z", "latest_research_run_id": "security_refresh_next50_clean_20260704", "latest_profile_run_id": "security_refresh_next50_clean_20260704", "market_data_in_lane_as_of": "May 20, 2026 valuation snapshot; exact July 3, 2026 close, beta, volatility, short interest, and peer valuation table were not retrieved in the source run.", "web_links_checked_as_of": "2026-07-05", "chart_data_as_of": "latest available from /api/securities/GH/chart", "chart_data_source": "Local report API backed by discovery daily_ohlc and derived weekly rows.", "latest_source_diagnostics": { "has_stale_sources": false, "missing_required_source_ids": [ "last_4_earnings_call_transcripts", "2026_DEF14A", "point_in_time_market_data_close_2026_07_03" ], "source_count": 10, "stale_source_ref_ids": [], "diagnostic_gaps": [ "Last four full earnings-call transcripts were not retrieved in the source pass.", "2026 DEF 14A was not retrieved, so governance and incentive analysis relies on governance documents plus 10-K/SBC disclosures.", "Current point-in-time market data was incomplete; valuation uses the May 20, 2026 close and latest share count plus July 2026 price-action context.", "Exact peer valuation data was not retrieved; peer context remains qualitative.", "Segment-level profitability and Shield-specific unit economics are not disclosed." ] }, "limitations": [ "The dashboard summarizes the filed GH lane rather than refreshing canonical research.", "Operating evidence remains anchored to the latest paired GH source projections generated 2026-07-04T17:26:59.231168Z.", "Market valuation uses the source run's May 20, 2026 close and share-count frame; live price and market-cap values resolve only when the local report API is running.", "Web checks were used as dated route and source validation; they do not replace the canonical knowledge lane.", "The page does not store chart overlay definitions, page-specific trigger prices, or portfolio instructions." ] }, "source_trail": { "canonical_knowledge_lane": "../../../knowledge/wiki/lanes/security/gh.md", "profile_source_id": "security_profile__gh__security_refresh_next50_clean_20260704", "research_source_id": "security_research__gh__security_refresh_next50_clean_20260704", "latest_profile_output": "../../../knowledge/raw/sources/security_profile__gh__security_refresh_next50_clean_20260704/output.md", "latest_profile_output_json": "../../../knowledge/raw/sources/security_profile__gh__security_refresh_next50_clean_20260704/output.json", "latest_profile_manifest": "../../../knowledge/raw/sources/security_profile__gh__security_refresh_next50_clean_20260704/source.json", "latest_profile_output_hash": "sha256:5e71c6e676098b1479ea793070b889177a9931fdd12a16a18ada22a366d26274", "latest_research_output": "../../../knowledge/raw/sources/security_research__gh__security_refresh_next50_clean_20260704/output.md", "latest_research_output_json": "../../../knowledge/raw/sources/security_research__gh__security_refresh_next50_clean_20260704/output.json", "latest_research_manifest": "../../../knowledge/raw/sources/security_research__gh__security_refresh_next50_clean_20260704/source.json", "latest_research_output_hash": "sha256:cfa1bd1029bd6be50dbdb14578d47db029c675c657f37cb8ceb3bfcc0b856d99", "profile_generated_at_utc": "2026-07-04T17:26:59.231168Z", "profile_as_of_utc": "2026-07-04T17:26:59.231168Z", "profile_exported_at_utc": "2026-07-05T04:36:20Z", "research_generated_at_utc": "2026-07-04T17:26:59.231168Z", "research_exported_at_utc": "2026-07-05T04:36:20Z", "profile_used_reused_inputs": true, "research_used_reused_inputs": false, "source_run_id": "security_refresh_next50_clean_20260704", "source_child_ids": [ "security_profile__gh", "security_research__gh" ], "upstream_hashes": { "security_research": "cfa1bd1029bd6be50dbdb14578d47db029c675c657f37cb8ceb3bfcc0b856d99", "sector_context_health_care": "420cdd34b76a571e0eb83975ab8e2b93b1efebaecb7aa22633d5543897b595e7" }, "source_claims_projected": [ "C-001", "C-002", "C-003", "C-004", "C-005", "C-006", "C-007", "C-008", "C-009", "C-010", "C-011", "C-012" ], "source_evidence_ids_projected": [ "E-006", "E-007", "E-008", "E-009", "E-010", "E-012", "E-013", "E-014", "E-015", "E-017", "E-018", "E-019", "E-020", "E-021", "E-022", "E-024", "E-025", "E-026", "E-027" ], "profile_object_ids_projected": [ "gh_path_utilization_screening", "gh_path_reimbursement_guidelines", "gh_path_funding_convertibles", "gh_path_tools_biopharma", "gh_path_input_commercial_spend", "fcst_revenue_growth", "fcst_shield_adoption", "fcst_margin_cash_flow", "fcst_per_share_dilution", "exp_oncology_and_total_revenue_stay_strong", "exp_shield_scales_but_reimbursement_decides_quality", "exp_margin_conversion_lags_revenue", "exp_capital_structure_matters_more_after_2026", "scn_base_high_growth_cash_burn_narrows", "scn_upside_shield_and_oncology_exceed", "scn_downside_reimbursement_or_guideline_disappointment", "scn_downside_funding_and_convert_pressure", "trig_confirm_q2_beat_and_guide", "trig_confirm_shield_coverage_volume", "trig_invalidate_shield_volume_or_asp", "trig_invalidate_oncology_volume_slowdown", "trig_watch_commercial_spend_leverage", "trig_invalidate_fcf_burn_miss", "trig_watch_convertible_path", "trig_watch_clinical_positioning", "KU-001", "KU-002", "KU-003", "KU-004", "U006", "gku_policy_liquidity_path" ], "source_refs_projected": [ "S-2026-Q1-10Q", "S-Q1-2026-PR", "S-Q1-2026-PRES", "S-2025-10K", "S-2024-10K", "S-IBD-MAY2026", "S-IBD-JUL2026", "S-IBD-Q3-2025", "S-BARRONS-JUL2026", "S-GOV-DOCS" ], "source_ref_urls": { "S-2026-Q1-10Q": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001576280/2ce12c49-354c-43e5-9227-72263f7a257c.pdf", "S-Q1-2026-PR": "https://investors.guardanthealth.com/press-releases/press-releases/2026/Guardant-Health-Reports-First-Quarter-2026-Financial-Results-and-Increases-2026-Revenue-Guidance/default.aspx", "S-Q1-2026-PRES": "https://s206.q4cdn.com/462472367/files/doc_financials/2026/q1/Guardant-Health-Q1-2026-Earnings-Presentation-vF-1.pdf", "S-2025-10K": "https://s206.q4cdn.com/462472367/files/doc_financials/2025/ar/2025-Annual-Report-of-Form-10K.pdf", "S-2024-10K": "https://s206.q4cdn.com/462472367/files/doc_financials/2024/ar/Guardant-Health-2024-10K.pdf", "S-IBD-MAY2026": "https://www.investors.com/news/technology/guardant-health-stock-blood-test-cancer-detection/", "S-IBD-JUL2026": "https://www.investors.com/stock-lists/ibd-50/healthcare-stocks-sector-investing-markets-ibd-50-list-eli-lilly/", "S-IBD-Q3-2025": "https://www.investors.com/news/technology/guardant-health-stock-guardant-health-earnings-q3-2025/", "S-BARRONS-JUL2026": "https://www.barrons.com/articles/cancer-screens-grail-stock-fda-048c4027", "S-GOV-DOCS": "https://investors.guardanthealth.com/governance/governance-documents/default.aspx" }, "local_chart_endpoints": [ "/api/securities/GH/chart?frequency=daily&window=9m&as_of=latest", "/api/securities/GH/chart?frequency=weekly&window=5y&as_of=latest" ], "route_registry_route": "../../assets/security-page-routes.js#GH", "chart_level_registry_route": "../../assets/chart-level-rules.js#GH", "fallback_chart_route": "../index.html?ticker=GH", "raw_source_file_presence": { "profile": { "source_id": "security_profile__gh__security_refresh_next50_clean_20260704", "exists": true, "output_md": true, "output_json": true, "source_json": true, "run_id": "security_refresh_next50_clean_20260704", "child_id": "gh", "generated_at_utc": "2026-07-04T17:26:59.231168Z", "exported_at_utc": "2026-07-05T04:36:20Z" }, "research": { "source_id": "security_research__gh__security_refresh_next50_clean_20260704", "exists": true, "output_md": true, "output_json": true, "source_json": true, "run_id": "security_refresh_next50_clean_20260704", "child_id": "gh", "generated_at_utc": "2026-07-04T17:26:59.231168Z", "exported_at_utc": "2026-07-05T04:36:20Z" } } }, "web_source_trail": { "checked_at": "2026-07-05", "official_links": [ { "label": "Guardant Health investor relations", "url": "https://investors.guardanthealth.com/", "publication_date": null, "checked_at": "2026-07-05", "dated_note": "IR route checked July 5, 2026; used as company-hosted navigation for releases, events, presentations, financials, and governance." }, { "label": "Guardant Health Q1 2026 earnings release", "url": "https://investors.guardanthealth.com/press-releases/press-releases/2026/Guardant-Health-Reports-First-Quarter-2026-Financial-Results-and-Increases-2026-Revenue-Guidance/default.aspx", "publication_date": "2026-05-07", "checked_at": "2026-07-05", "dated_note": "Company release route checked July 5, 2026; report uses the filed lane's Q1 revenue, gross margin, FCF, and raised 2026 guidance facts." }, { "label": "Guardant Health Q1 2026 Form 10-Q", "url": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001576280/2ce12c49-354c-43e5-9227-72263f7a257c.pdf", "publication_date": "2026-05-07", "checked_at": "2026-07-05", "dated_note": "Quarterly filing route for the period ended March 31, 2026; report uses lane-filed balance-sheet, cash-flow, segment, and share-count context." }, { "label": "Guardant Health Q1 2026 earnings presentation", "url": "https://s206.q4cdn.com/462472367/files/doc_financials/2026/q1/Guardant-Health-Q1-2026-Earnings-Presentation-vF-1.pdf", "publication_date": "2026-05-07", "checked_at": "2026-07-05", "dated_note": "Presentation route checked July 5, 2026; retained as supporting operating context rather than replacing the lane synthesis." }, { "label": "Guardant Health SEC filings page", "url": "https://investors.guardanthealth.com/financials/sec-filings/default.aspx", "publication_date": null, "checked_at": "2026-07-05", "dated_note": "Company-hosted filings route checked July 5, 2026 for follow-on filing discovery." }, { "label": "SEC EDGAR company browse", "url": "https://www.sec.gov/edgar/browse/?CIK=0001576280&owner=exclude", "publication_date": null, "checked_at": "2026-07-05", "dated_note": "SEC browse route for CIK 1576280 retained as the primary filing discovery fallback." }, { "label": "Guardant Health governance documents", "url": "https://investors.guardanthealth.com/governance/governance-documents/default.aspx", "publication_date": null, "checked_at": "2026-07-05", "dated_note": "Governance route checked July 5, 2026; latest proxy compensation tables were still treated as a source gap because they were not normalized in the filed source pass." } ], "street_view_items": [ { "provider": "Guardant Health investor relations", "url": "https://investors.guardanthealth.com/stock-info/analyst-coverage/default.aspx", "as_of": "2026-07-05", "detail": "Official analyst coverage route checked July 5, 2026. Hard ownership, short interest, beta, volatility, and peer valuation table remain source gaps in the filed lane." } ] }, "chart": { "ticker": "GH", "initializer": "assets/report.js initializeSecurityChartPage reads data-security-ticker=\"GH\"", "api_required": true, "daily_endpoint": "/api/securities/GH/chart?frequency=daily&window=9m&as_of=latest", "weekly_endpoint": "/api/securities/GH/chart?frequency=weekly&window=5y&as_of=latest", "price_source": "Local report API backed by discovery daily_ohlc and derived weekly rows.", "instrument_source": "Local report API backed by discovery instruments.", "chart_level_registry_route": "../../assets/chart-level-rules.js#GH", "route_registry_route": "../../assets/security-page-routes.js#GH", "fallback_route": "../index.html?ticker=GH", "overlay_policy": "Do not store page-specific chart overlays in report.json or HTML." }, "page_sections": [ { "id": "selected-security", "title": "Selected-Security Chart", "role": "Live local API chart host and chart-rule attachment point." }, { "id": "current-company-view", "title": "Current Company Proof Window", "role": "Setup, measured base, proof issue, valuation context, and next evidence." }, { "id": "selected-security-trade-plan", "title": "Selected Security Trade Plan", "role": "Hidden host for generated trade-plan cards from the shared chart-level registry." }, { "id": "business-profile-exposure", "title": "Business Profile, Segments, And Exposure", "role": "Business model, disclosure map, and exposure cards." }, { "id": "relative-value-drivers", "title": "Relative Value And Drivers", "role": "Revenue, margin, and per-share drivers from the filed lane." }, { "id": "guidance-path", "title": "Guidance Path And Tests", "role": "Guidance questions and confirm/warn evidence." }, { "id": "operating-evidence-kpis", "title": "KPIs And Catalysts", "role": "Operating evidence tiles and next catalyst window." }, { "id": "financial-quality-capital-allocation", "title": "Financial Quality And Capital Allocation", "role": "Liquidity, cash burn, convertibles, SBC, and growth-first capital allocation." }, { "id": "competitive-position", "title": "Competitive Position", "role": "Proven platform evidence versus unproven commercial and clinical positioning." }, { "id": "ownership-flows-valuation-street", "title": "Ownership, Flows, Valuation, And Tape", "role": "Tape, valuation, and street-view gaps." }, { "id": "scenario-assessment", "title": "Scenario Assessment", "role": "Base, upside, and downside scenario cards." }, { "id": "monitoring-triggers", "title": "Monitoring Trigger Board", "role": "Evidence checks for Q2 results, Shield, operating leverage, and capital structure." }, { "id": "risks-invalidations-quality-flags", "title": "Risks, Invalidations, And Quality Flags", "role": "Risk punch cards for reimbursement, commercial efficiency, clinical positioning, and capital structure." }, { "id": "diagnostics-freshness-unknowns", "title": "Freshness And Known Unknowns", "role": "Source freshness, web checks, and diligence gaps." }, { "id": "links-filings", "title": "Links And Filings", "role": "Canonical lane, metadata, company, SEC, filing, presentation, and fallback chart routes." } ], "machine_provenance_limitations": [ "Raw source ids, claim ids, evidence ids, object ids, hashes, and artifact routes are retained in metadata rather than visible HTML.", "The report is a projection contract and should not become a second canonical research layer.", "Web-source checks are dated route validation and source context, not a canonical research refresh.", "No chart overlays, chart trigger prices, static guide lines, or portfolio instructions are stored in this report." ], "revision": { "generated_by": "report-security-page automation worker", "generated_for_phase": "report-security-pages", "source_run_id": "security_refresh_next50_clean_20260704", "created_or_refreshed_at": "2026-07-05T09:12:41-07:00", "status": "refreshed", "notes": [ "Replaced the earlier auto-compressed GH page with a hand-shaped OUST-pattern article projection.", "Removed visible claim/evidence IDs and raw artifact mechanics from the HTML.", "Added output hashes, dated web checks, complete source-route metadata, and page-section alignment.", "Kept chart overlays and trade-plan rules delegated to shared registries." ] } }